1 report

The drug candidate is in Phase II stage for peanut allergy in adults and pediatrics, grass pollen allergy and dermatitis globally.

  • Antifungal
  • Blood Disease
  • Digestive System Disorder
  • Monoclonal Antibody
  • United States